Organogenesis Holdings Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue37.2M225.1M150.5M100.8M86.7M126.7M115.2M130.2M
Cost of Goods Sold38.1M49.9M36.3M27.6M23.7M31.1M26.8M29.2M
Gross Profit-914K175.2M114.2M73.1M63.0M95.6M88.4M101.0M
R&D Expenses15.2M10.3M13.2M10.4M10.6M11.5M10.3M15.6M
Operating Expenses64.1M109.9M92.6M84.0M83.1M85.4M82.1M114.9M
Operating Income-65.0M65.2M21.6M-10.8M-20.2M10.2M6.2M-13.9M
Other Income / Gains-3.4M-1.8M-489K-1.0M-5.6M34K-419K-648K
Net Income-56.2M43.7M21.6M-9.4M-18.8M7.7M12.3M-17.0M
EPS (Diluted)-0.440.280.11-0.096-0.170.0450.093-0.13
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio-0.0250.7780.7590.7260.7260.7550.7670.776
General And Administrative Expenses0000070.0M00
Selling And Marketing Expenses000003.8M00
Selling General And Administrative Expenses65.2M100.2M79.7M73.8M72.5M73.9M71.8M76.5M
Other Expenses-16.2M-536K-377K-226K00022.8M
Cost And Expenses102.3M159.8M128.8M111.6M106.9M116.4M108.9M144.1M
Interest Income380K236K415K669K961K000
Interest Expense00000-61K471K620K
Depreciation And Amortization12.4M7.0M7.0M6.7M6.3M4.4M4.4M4.2M
Ebitda-56.1M70.4M28.1M-5.2M-19.5M14.6M10.7M-9.7M
Ebitdaratio-1.5070.3130.187-0.051-0.2250.1160.093-0.075
Operating Income Ratio-1.7470.290.144-0.107-0.2330.0810.054-0.107
Income Before Tax-68.5M63.4M21.2M-11.8M-25.8M10.3M5.8M-14.5M
Income Before Tax Ratio-1.8390.2820.141-0.117-0.2970.0810.051-0.112
Income Tax Expense-12.3M19.7M-407K-2.4M-6.9M2.6M-6.5M2.5M
Net Income Ratio-1.5090.1940.143-0.093-0.2170.0610.107-0.131
Epsdiluted-0.440.270.11-0.096-0.170.0440.092-0.13
Weighted Average Shs Out127.8M126.9M126.9M126.9M126.3M131.7M132.6M132.6M
Weighted Average Shs Out Dil127.8M132.2M130.8M126.9M126.3M132.2M133.9M132.6M